Valion Bio, Inc. (Nasdaq: VBIO) (formerly Tivic Health Systems, Inc.), a clinical-stage immunotherapeutics company developing Entolimod™ for Acute Radiation Syndrome (ARS) and oncology supportive care ...

Scientists at Université de Montréal's Institute for Research in Immunology and Cancer have developed a new database that ...

HENDERSON, Nev.--(BUSINESS WIRE)--Zura Bio Limited (Nasdaq: ZURA) (“Zura Bio” or the “Company”), a clinical-stage, multi-asset immunology company dedicated to developing novel dual-pathway antibodies ...

Bio-Path Holdings, Inc. has announced significant progress with its drug BP1001-A, which has shown potential as a treatment for obesity and Type 2 diabetes in recent preclinical studies. The research ...

Educators and researchers are increasingly integrating AI platforms like NotebookLM, GitHub Copilot, and structured prompt engineering into biology teaching and structural biology research. These ...

WASHINGTON--(BUSINESS WIRE)--Today, the Biotechnology Innovation Organization (BIO) released the largest ever study of clinical development success rates. The study, conducted in partnership with ...

UCSD’s biology curriculum spans data-driven courses like Biostatistics and field-focused subjects like Organismic and Evolutionary Biology. Combining these with methods such as active recall, ...

– Series A financing co-led by RA Capital, a16z Bio+Health and Nextech Invest, and includes participation from existing investors Emerson Collective Investments (managed by Yosemite), GV (Google ...

INmune Bio, Inc. announced promising results from a collaboration with Dr. Kirsty Dixon at Virginia Commonwealth University, showing that their treatment XPro™ effectively prevents both short- and ...

LONDON & SAN FRANCISCO, February 24, 2026--(BUSINESS WIRE)--Verdiva Bio Limited ("Verdiva Bio" or "the Company") a clinical-stage biopharmaceutical company focused on developing innovative therapies ...